Corinne Gomez Selected Research

SAR125844

10/2017

Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Corinne Gomez Research Topics

Disease

2	Neoplasms (Cancer) 01/2018 - 10/2017
1	Stomach Neoplasms (Stomach Cancer) 10/2017

Drug/Important Bio-Agent (IBA)

1	2- (2- (2- methyl- 2,3- dihydroindol- 1- yl)- 2- oxoethyl)- 6- morpholin- 4- yl- 3H- pyrimidin- 4- oneIBA 01/2018
1	TensinsIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	SAR125844IBA 10/2017
1	Tyrosine Kinase InhibitorsIBA 10/2017